Literature DB >> 15791390

Risk factors for critical illness polyneuromyopathy.

J Bednarík1, P Vondracek, L Dusek, E Moravcova, I Cundrle.   

Abstract

Although numerous clinical, laboratory, and pharmacological variables have been reported as significant risk factors for critical illness polyneuromyopathy (CIPM), there is still no consensus on the aetiology of this condition. Objectives of the study were to assess the clinical and electrophysiological incidence and risk factors for CIPM.A cohort of critically ill patients was observed prospectively for a one-month period and the association between neuromuscular involvement and various potential risk factors was evaluated. Sixty one critically ill patients completed the follow-up (30 women, 31 men, median age 59 years).CIPM development was detected clinically in 17 patients (27.9 %) and electrophysiologically in 35 patients (57.4 %). CIPM was significantly associated with the presence and duration of systemic inflammatory response syndrome and the severity of multiple, respiratory, central nervous, and cardiovascular organ failures. The median duration of mechanical ventilation was significantly longer in patients with CIPM than in those without (16 vs 3 days, p<0.001). Independent predictors of CIPM obtainable within the 1(st) week of critical illness were the admission sequential organ failure assessment score (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.02-1.36), the 1(st) week total sequential organ failure assessment scores (OR, 1.14; 95 % CI, 1.06-1.46) and the 1(st) week duration of systemic inflammatory response syndrome (OR, 1.05; 95% CI, 1.01-1.15). They were able to correctly predict the development of CIPM at the end of the 1(st) week in about 80% of critically ill cases.In conclusion, the presence and duration of systemic inflammatory response syndrome and the severity of multiple and several organ failures are associated with increased risk of the development of CIPM.

Entities:  

Mesh:

Year:  2005        PMID: 15791390     DOI: 10.1007/s00415-005-0654-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Critical illness myopathy.

Authors:  D Lacomis; D W Zochodne; S J Bird
Journal:  Muscle Nerve       Date:  2000-12       Impact factor: 3.217

2.  Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy?

Authors:  T J Geller; K Kaiboriboon; G A Fenton; G R Hayat
Journal:  Neuromuscul Disord       Date:  2001-09       Impact factor: 4.296

3.  Application of SOFA score to trauma patients. Sequential Organ Failure Assessment.

Authors:  M Antonelli; R Moreno; J L Vincent; C L Sprung; A Mendoça; M Passariello; L Riccioni; J Osborn
Journal:  Intensive Care Med       Date:  1999-04       Impact factor: 17.440

4.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM.

Authors:  R Moreno; J L Vincent; R Matos; A Mendonça; F Cantraine; L Thijs; J Takala; C Sprung; M Antonelli; H Bruining; S Willatts
Journal:  Intensive Care Med       Date:  1999-07       Impact factor: 17.440

Review 5.  Neuromuscular complications in the ICU: the spectrum of critical illness-related conditions causing muscular weakness and weaning failure.

Authors:  E F Hund
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

6.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.

Authors:  D W Zochodne; C F Bolton; G A Wells; J J Gilbert; A F Hahn; J D Brown; W A Sibbald
Journal:  Brain       Date:  1987-08       Impact factor: 13.501

7.  Critical illness polyneuromyopathy after artificial respiration.

Authors:  A A Op de Coul; G A Verheul; A C Leyten; R L Schellens; J L Teepen
Journal:  Clin Neurol Neurosurg       Date:  1991       Impact factor: 1.876

8.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.

Authors:  Josef Bednarik; Zdenek Lukas; Petr Vondracek
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

9.  Critical illness poly-neuropathy following severe hyperpyrexia.

Authors:  P T Wilmshurst; D F Treacher; P L Lantos; C M Wiles
Journal:  QJM       Date:  1995-05

10.  Acute polyneuropathy in critically ill patients.

Authors:  J B Lopez Messa; A García
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

View more
  52 in total

1.  Review of Critical Illness Myopathy and Neuropathy.

Authors:  Starane Shepherd; Ayush Batra; David P Lerner
Journal:  Neurohospitalist       Date:  2016-08-23

Review 2.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

Review 3.  Dysregulation of sodium channel gating in critical illness myopathy.

Authors:  James W Teener; Mark M Rich
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

Review 4.  Quantitative neuromuscular ultrasound in intensive care unit-acquired weakness: A systematic review.

Authors:  Aaron Bunnell; John Ney; Alfred Gellhorn; Catherine L Hough
Journal:  Muscle Nerve       Date:  2015-09-21       Impact factor: 3.217

Review 5.  The ABCDEF Bundle in Critical Care.

Authors:  Annachiara Marra; E Wesley Ely; Pratik P Pandharipande; Mayur B Patel
Journal:  Crit Care Clin       Date:  2017-04       Impact factor: 3.598

6.  [Critical illness myopathy and neuropathy (CRIMYN). Electroneurographic classification].

Authors:  P Baum; S Bercker; T Villmann; J Classen; W Hermann
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

7.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

8.  Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers.

Authors:  Christiane G Frick; Heidrun Fink; Maria L Gordan; Barbara Eckel; J A Jeevendra Martyn; Manfred Blobner
Journal:  Intensive Care Med       Date:  2007-10-20       Impact factor: 17.440

9.  Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure.

Authors:  Anna-Giulia Brunello; Matthias Haenggi; Oliver Wigger; Francesca Porta; Jukka Takala; Stephan M Jakob
Journal:  Intensive Care Med       Date:  2009-09-16       Impact factor: 17.440

Review 10.  ICU-Acquired Weakness.

Authors:  Sarah E Jolley; Aaron E Bunnell; Catherine L Hough
Journal:  Chest       Date:  2016-04-07       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.